,63,64,65 Thus, by employing third generation FNA, a promising biosafety nanomaterial with excellent delivery efficiency for siRNA, we targeted the CCL/CCR2 axis to eliminate macrophage accumulation in the IPF murine model.42 The gene discussed is CCR2; the disease is idiopathic pulmonary fibrosis.